Approvals/HSA/CAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE

Approved

THERAPEUTIC

CAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE

Fareva Pau (FRANCE)Sterigenics Belgium (Fleurus) (Contract Sterilization) (BELGIUM)🇸🇬 Health Sciences Authority

Approval Date: Jul 8, 2026
Approval ID: fff001c896de468f
Company: Fareva Pau (FRANCE)Sterigenics Belgium (Fleurus) (Contract Sterilization) (BELGIUM)
Type: Therapeutic

Approval Id: fff001c896de468f
Drug Name: CAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE
Product Name: CAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE
Approval Number: SIN17580P
Approval Date: 2026-07-08
Registrant: GENSCI SINGAPORE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INJECTION, SUSPENSION, EXTENDED RELEASE
Route Of Administration: SUBCUTANEOUS

Approved

Agency

HSA

Country

🇸🇬

Approval Date

Jul 8, 2026

Approval ID

fff001c896de468f

Type

Therapeutic